• NSP15 Screening Identifies Thymopentin and Oleuropein

  2026-09-18

  This 2021 study used structure-based virtual screening and molecular dynamics simulations to identify thymopentin and oleuropein as high-priority natural-product binders of SARS-CoV-2 NSP15. The work provides a hypothesis-generating framework for targeting viral RNA-processing and immune-evasion mechanisms, while its computational findings still require biochemical, cellular, and infection-model validation.

• Tranexamic Acid for Fibrinolysis Workflows

  2026-09-18

  Build more informative clot-stability, plasmin, and cell-adhesion experiments with Tranexamic Acid, an antifibrinolytic agent that connects molecular inhibition to biomaterial testing. This workflow emphasizes controlled concentrations, rapid solution handling, and factor-separated validation for wound-dressing and fibrinolysis research.

• GM 6001 (Galardin) for MMP Research

  2026-09-17

  GM 6001 (Galardin) provides broad MMP suppression for matrix-remodeling, migration, and signaling assays. This practical guide connects meniscal healing research, EGFR transactivation inhibition, cancer cell proliferation modulation, and vascular smooth muscle cell migration inhibition to reproducible workflows and troubleshooting decisions.

• From Caspase-8 Signals to Caspase-3 Strategy

  2026-09-17

  A translational framework for converting caspase-8 mechanistic findings into quantitative caspase-3 activity measurement, with strategic guidance for assay selection, validation, and therapeutic interpretation.

• Clathrin-Mediated Entry of Grass Carp Reovirus

  2026-09-16

  Wang et al. combined pharmacological inhibition, transmission electron microscopy, and quantitative PCR to show that genotype III grass carp reovirus enters CIK cells through a clathrin-, dynamin-, and endosome-acidification-dependent pathway. The study also found that Latrunculin B did not block infection under the tested conditions, making the result useful for distinguishing clathrin-mediated uptake from an essential requirement for actin filament assembly.

• Lambda Protein Phosphatase for BMAL1 Studies

  2026-09-16

  Lambda Protein Phosphatase provides a practical dephosphorylation strategy for testing how BMAL1 phosphorylation influences phase-separated transcriptional hubs. This guide connects λ-PPase assay design with antibody validation, phosphorylation site validation, and functional circadian readouts.

• Metabolic Stress, DNA Repair, and Repaglinide

  2026-09-15

  Energy availability is emerging as a controllable variable in genome maintenance. This thought-leadership analysis connects recent AML findings on ATG4B, PRMT1, and MRE11 with a translational strategy for evaluating Repaglinide as a hypothesis-generating metabolic perturbation—not as a validated leukemia therapy.

• SFI Inhibits Glioma via SRC/PI3K/AKT Signaling

  2026-09-15

  The reference study combines network pharmacology with cell-based and mouse experiments to investigate how Shenqi Fuzheng injection suppresses glioma proliferation and migration. Its results identify SRC/PI3K/AKT signaling as a candidate mechanistic axis, while also showing cell-cycle arrest, reduced epithelial–mesenchymal transition markers, and slower tumor growth in a transplanted model.

• S1P/S1PR3 Drives Neuronal Apoptosis After ICH

  2026-09-14

  The reference study identifies an S1P–S1PR3 axis that links acute intracerebral hemorrhage with CCL2 and TNF-α induction, PI3K/AKT-associated signaling, and caspase-3 activation in neurons. Mouse and HT22-cell experiments indicate that pharmacological S1PR3 blockade reduces apoptosis and improves injury-associated outcomes, while also emphasizing the receptor- and tissue-dependent nature of S1P biology.

• HNF4A-AS1 Loss Drives Sorafenib Resistance in HCC

  2026-09-14

  The 2024 Theranostics study identifies liver-enriched lncRNA HNF4A-AS1 as a regulator of sorafenib-induced ferroptosis in hepatocellular carcinoma. Its loss increases DECR1, reduces intracellular polyunsaturated fatty acids, and promotes drug resistance through an METTL3–m6A–YTHDF3 RNA regulatory axis.

• Tigecycline and the New MDR Research Playbook

  2026-09-13

  Tigecycline is more than a broad-spectrum glycylcycline antibiotic: it is a useful translational probe for connecting ribosomal inhibition, resistant-pathogen phenotypes, mobile carbapenemase genes, and clinically relevant infection models. This article outlines a surveillance-informed framework for evaluating its value in multidrug-resistant bacteria research.

• Gefitinib Sensitizes Cisplatin-Resistant wtEGFR NSCLC

  2026-09-12

  This 2020 study identifies increased EGFR phosphorylation as a potential off-target component of Cisplatin resistance in wild-type EGFR non-small cell lung cancer models. It further shows that gefitinib combined with Cisplatin suppresses resistant-cell proliferation, promotes apoptosis, and inhibits H358R xenograft growth more effectively than either treatment alone.

• HHV-7 DNA in Refractory Ocular Toxoplasmosis

  2026-09-11

  Miyase et al. reported the first vitreous-fluid co-detection, to the authors’ knowledge, of Toxoplasma gondii and human herpesvirus 7 DNA in refractory ocular toxoplasmosis. The case suggests that HHV-7 reactivation may contribute to persistent inflammation, while also illustrating why intraocular sampling and multiplex PCR can refine diagnosis when empiric therapy fails.

• Lipo3K Transfection Reagent for GBM Studies

  2026-09-11

  Build reproducible PXDN–LDHA experiments in glioblastoma models with a low-toxicity lipid transfection reagent suited to plasmids, siRNA, and co-transfection workflows. Lipo3K supports difficult cell lines, serum-compatible delivery, and direct collection for downstream molecular and metabolic assays.

• Iron Deficiency, KDM4D, and MSC Quiescence

  2026-09-10

  A 2024 study identifies an iron-sensitive KDM4D–H3K9me3–PIK3R3 mechanism that regulates mesenchymal stem cell activation through PI3K-Akt-Foxo1 signaling. Its findings connect impaired epigenetic regulation under iron deficiency with reduced bone mass and provide a framework for testing pathway-level rescue strategies in osteoporosis research.

8073 records 1/539 page Next 12345 下5页 Last page